Synaptic protein CSF levels relate to memory scores in individuals without dementia

Synaptic protein CSF levels relate to memory scores in individuals without dementia

Background: We investigated how cerebrospinal fluid levels of synaptic proteins associate with memory function in normal cognition (CN) and mild cognitive impairment (MCI), and investigated the effect of amyloid positivity on these associations. Methods: We included 242 CN (105(43%) abnormal amyloid...

书目详细资料
Main Authors:	Wesenhagen, KEJ, de Leeuw, DM, Tomassen, J, Gobom, J, Bos, I, Vos, SJB, Martinez-Lage, P, Tainta, M, Popp, J, Peyratout, G, Tsolaki, M, Vandenberghe, R, Freund-Levi, Y, Verhey, F, Lovestone, S, Streffer, J, Dobricic, V, Blennow, K, Scheltens, P, Smit, AB, Bertram, L, Teunissen, CE, Zetterberg, H, Tijms, BM
格式:	Journal article
语言:	English
出版:	BioMed Central 2025

相似书籍

Synaptic protein CSF levels relate to memory scores in individuals without dementia
由: Kirsten E. J. Wesenhagen, et al.
出版: (2025-03-01)

CSF Proteomic Alzheimer’s Disease-Predictive Subtypes in Cognitively Intact Amyloid Negative Individuals
由: Betty Marije Tijms, et al.
出版: (2021-08-01)

APOE ε4 genotype-dependent cerebrospinal fluid proteomic signatures in Alzheimer’s disease
由: Elles Konijnenberg, et al.
出版: (2020-05-01)

Involvement of the choroid plexus in Alzheimer’s disease pathophysiology: findings from mouse and human proteomic studies
由: Delvenne, A, et al.
出版: (2024)

CSF proteomic profiles of neurodegeneration biomarkers in Alzheimer's disease
由: Delvenne, A, et al.
出版: (2024)

Involvement of the choroid plexus in Alzheimer’s disease pathophysiology: findings from mouse and human proteomic studies
由: Aurore Delvenne, et al.
出版: (2024-07-01)

Correction: Cerebrospinal fluid tau levels are associated with abnormal neuronal plasticity markers in Alzheimer’s disease
由: Pieter Jelle Visser, et al.
出版: (2022-05-01)

Cerebrospinal fluid tau levels are associated with abnormal neuronal plasticity markers in Alzheimer’s disease
由: Pieter Jelle Visser, et al.
出版: (2022-03-01)

Validation of plasma proteomic biomarkers relating to brain amyloid burden in the EMIF-Alzheimer's disease multimodal biomarker discovery cohort
由: Westwood, S, et al.
出版: (2020)

Inflammatory biomarkers in Alzheimer's disease plasma
由: Morgan, A, et al.
出版: (2019)

MRI predictors of amyloid pathology: results from the EMIF-AD multimodal biomarker discovery study
由: ten Kate, M, et al.
出版: (2018)

Discovery and validation of plasma proteomic biomarkers relating to brain amyloid burden by SOMAscan assay
由: Shi, L, et al.
出版: (2019)

Genome-Wide Association Study of Alzheimer’s Disease Brain Imaging Biomarkers and Neuropsychological Phenotypes in the European Medical Information Framework for Alzheimer’s Disease Multimodal Biomarker Discovery Dataset
由: Jan Homann, et al.
出版: (2022-03-01)

Multivariate GWAS of Alzheimer’s disease CSF biomarker profiles implies GRIN2D in synaptic functioning
由: Alexander Neumann, et al.
出版: (2023-10-01)

Sex-Specific Metabolic Pathways Were Associated with Alzheimer’s Disease (AD) Endophenotypes in the European Medical Information Framework for AD Multimodal Biomarker Discovery Cohort
由: Jin Xu, et al.
出版: (2021-11-01)

P-tau subgroups in AD relate to distinct amyloid production and synaptic integrity profiles
由: Kirsten E. J. Wesenhagen, et al.
出版: (2022-07-01)

Cerebrospinal fluid N-224 tau helps discriminate Alzheimer’s disease from subjective cognitive decline and other dementias
由: Claudia Cicognola, et al.
出版: (2021-02-01)

The EMIF-AD Multimodal Biomarker Discovery study: design, methods and cohort characteristics
由: Isabelle Bos, et al.
出版: (2018-07-01)

Cerebrospinal fluid biomarkers of neurodegeneration, synaptic integrity, and astroglial activation across the clinical Alzheimer's disease spectrum
由: Bos, I, et al.
出版: (2019)

Four subgroups based on tau levels in Alzheimer’s disease observed in two independent cohorts
由: Flora H. Duits, et al.
出版: (2021-01-01)

Plasma Proteomic Biomarkers Relating to Alzheimer’s Disease: A Meta-Analysis Based on Our Own Studies
由: Liu Shi, et al.
出版: (2021-07-01)

Harmonization and standardization of biofluid‐based biomarker measurements for AT(N) classification in Alzheimer's disease
由: Chiara Giangrande, et al.
出版: (2023-07-01)

Peptidome analysis of cerebrospinal fluid by LC-MALDI MS.
由: Mikko Hölttä, et al.
出版: (2012-01-01)

Abnormal cerebrospinal fluid levels of amyloid and tau are associated with cognitive decline over time in cognitively normal older adults: A monozygotic twin study
由: Jori Tomassen, et al.
出版: (2022-01-01)

Predicting AT(N) pathologies in Alzheimer’s disease from blood-based proteomic data using neural networks
由: Yuting Zhang, et al.
出版: (2022-11-01)

Diagnostic value of cerebrospinal fluid neurofilament light protein in neurology: A systematic review and meta-analysis
由: Bridel, C, et al.
出版: (2019)

Neuroligin-1 in brain and CSF of neurodegenerative disorders: investigation for synaptic biomarkers
由: Elena Camporesi, et al.
出版: (2021-02-01)

CSF proteomic signature predicts progression to Alzheimer's disease dementia
由: Eleonora M. Vromen, et al.
出版: (2022-01-01)

Levels of ADAM10 are reduced in Alzheimer’s disease CSF
由: Aitana Sogorb-Esteve, et al.
出版: (2018-07-01)

Cerebrospinal fluid biomarker panel for synaptic dysfunction in Alzheimer's disease
由: Johanna Nilsson, et al.
出版: (2021-01-01)

Spitting image: can saliva biomarkers reflect Alzheimer's disease?
由: Nicholas J. Ashton, et al.
出版: (2021-06-01)

Editorial: Blood Biomarkers of Neurodegenerative Diseases
由: Thomas K. Karikari, et al.
出版: (2022-06-01)

Amyloid-independent atrophy patterns predict time to progression to dementia in mild cognitive impairment
由: Mara ten Kate, et al.
出版: (2017-09-01)

Comparing CSF amyloid‐beta biomarker ratios for two automated immunoassays, Elecsys and Lumipulse, with amyloid PET status
由: Eline A. J. Willemse, et al.
出版: (2021-01-01)

Corrigendum to “Use of the tau protein-to-peptide ratio in CSF to improve diagnostic classification of Alzheimer’s disease” [Clin. Mass Spectrom. 14 (Part B) (2019) 74–82]
由: Karl Hansson, et al.
出版: (2022-11-01)

Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics
由: Henrik Zetterberg, et al.
出版: (2021-02-01)

Changes in Adiposity and Cerebrospinal Fluid Biomarkers Following a Modified Mediterranean Ketogenic Diet in Older Adults at Risk for Alzheimer’s Disease
由: Tina E. Brinkley, et al.
出版: (2022-06-01)

Decision tree supports the interpretation of CSF biomarkers in Alzheimer's disease
由: Rosha Babapour Mofrad, et al.
出版: (2019-12-01)

Early diagnosis of silent coronary artery disease in diabetic subjects - are intense efforts worth while?
由: KEJ Airaksinen
出版: (2001-07-01)

Salivary Biomarkers for Alzheimer’s Disease and Related Disorders
由: Nicholas J. Ashton, et al.
出版: (2019-12-01)